Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market - Global Industry Analysis, Trends, Market Size, and Forecasts to 2025 - ResearchAndMarkets.com

DUBLIN--()--The "Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

The report on the global chronic obstructive pulmonary disease therapeutics market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on chronic obstructive pulmonary disease therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on chronic obstructive pulmonary disease therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global chronic obstructive pulmonary disease therapeutics market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global chronic obstructive pulmonary disease therapeutics market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Persistent rise in the number of COPD cases globally
  • Increasing the number of tobacco smokers and prolong exposure to polluted air environments

2) Restraints

  • Lack of knowledge and awareness regarding COPD indication and symptoms

3) Opportunities

  • Strong pipeline drugs and rising government initiatives

Key Topics Covered:

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Chronic Obstructive Pulmonary Disease Therapeutics Market Highlights

2.2. Chronic Obstructive Pulmonary Disease Therapeutics Market Projection

2.3. Chronic Obstructive Pulmonary Disease Therapeutics Market Regional Highlights

3. Global Chronic Obstructive Pulmonary Disease Therapeutics Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. Growth Matrix Analysis

3.4.1. Growth Matrix Analysis by Drug Class

3.4.2. Growth Matrix Analysis by Distribution Channel

3.4.3. Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Chronic Obstructive Pulmonary Disease Therapeutics Market

4. Chronic Obstructive Pulmonary Disease Therapeutics Market Macro Indicator Analysis

5. Global Chronic Obstructive Pulmonary Disease Therapeutics Market by Drug Class

5.1. Bronchodilators

5.2. Combination

5.3. Phosphodiesterase Type 4 Inhibitors

5.4. Mucokinetics

5.5. Corticosteroids

5.6. Other Drug Class

6. Global Chronic Obstructive Pulmonary Disease Therapeutics Market by Distribution Channel

6.1. Online Pharmacies

6.2. Hospital Pharmacies

6.3. Retail Pharmacies

7. Global Chronic Obstructive Pulmonary Disease Therapeutics Market by Region 2019-2025

7.1. North America

7.1.1. North America Chronic Obstructive Pulmonary Disease Therapeutics Market by Drug Class

7.1.2. North America Chronic Obstructive Pulmonary Disease Therapeutics Market by Distribution Channel

7.1.3. North America Chronic Obstructive Pulmonary Disease Therapeutics Market by Country

7.2. Europe

7.3. Asia-Pacific

7.4. RoW

8. Company Profiles and Competitive Landscape

8.1. Competitive Landscape in the Global Chronic Obstructive Pulmonary Disease Therapeutics Market

8.2. Companies Profiles

8.2.1. Pfizer Inc.

8.2.2. Adamis Laboratories, Inc.

8.2.3. AstraZeneca plc

8.2.4. Boehringer Ingelheim Pharmaceuticals, Inc.

8.2.5. Novartis AG

8.2.6. Sunovion Pharmaceuticals, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/urxg6i

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Respiratory Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Respiratory Drugs